• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 期刊论文
  5. GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma as

GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma as

来源 :Hepatobiliary & Pancreatic Diseases International | 被引量 : 0次 | 上传用户：liongliong477
【摘 要】
：
BACKGROUND:The incidence of hepatocellular carcinoma (HCC)in China is closely related to the population infected with hepatitis B virus(HBV).HCC cells with HBV
【出 处】
：
Hepatobiliary & Pancreatic Diseases International
【发表日期】
：
2011年2期
【关键词】
：
HBsAg-αepitope GLYPICAN 3 hepatocellular carcinoma hepatitis B virus protein eng 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND:The incidence of hepatocellular carcinoma (HCC)in China is closely related to the population infected with hepatitis B virus(HBV).HCC cells with HBV secrete soluble HBsAg into blood but do not express it on the cell membrane This study aimed to
其他文献
Hepatocyte differentiation of human fibroblasts from cirrhotic liver in vitro and in vivo
BACKGROUND:Mesenchymal stem cells(MSCs)and fibro-blasts have intimate relationships,and the phenotypic homology between fibroblasts and MSCs has been recently d
期刊
FIBROBLASTSHEPATOCYTESmesenchymal-epithelialtransitionfibroblasts hepatocyt
Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats
BACKGROUND:Hepatic fibrosis is a necessary step in the development of hepatic cirrhosis.In this study we used lentiviral vector-mediated transfection technology
期刊
PEROXISOMEproliferator-activatedreceptorGAMMAHEPATICFIBROSISHEPATICstella
Clinical management of hepatitis B virus infection correlated with liver transplantation
BACKGROUND:As a radical cure for post-hepatitis B virus (HBV)-related liver cirrhosis and hepatocellular carcinoma,liver transplantation has been applied in man
期刊
HEPATITISBVACCINATIONHEPATITISBIMMUNOGLOBULINLAMIVUDINElivertransplantat
Protective effect of probiotics on intestinal barrier function in malnourished rats after liver tran
BACKGROUND: Most patients waiting for liver transplantation have end-stage liver diseases with malnutrition, which is prone to induce intestinal barrier dysfunc
期刊
liverTRANSPLANTATIONPROBIOTICSINTESTINALMICROFLORAINTESTINALBARRIERfuncti
Fulminant liver failure models with subsequent encephalopathy in the mouse
BACKGROUND:A reliable model of fulminant liver failure (FLF) is urgently required in this research field.This study aimed to develop a murine FLF model.METHODS:
期刊
ANIMALmodelacuteliverfailureAZOXYMETHANEGALACTOSAMINEtumorNECROSISFACTO
Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarc
BACKGROUND:Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an uncommon subtype of primary hepatic carcinoma,and its prognosis is poor.This
期刊
LIVERNEOPLASMSHEPATOCELLULARCARCINOMACHOLANGIOCARCINOMAPROGNOSISstemcells
Evaluation outcomes of donors in living dono liver transplantation: a single-center analysis of 132
BACKGROUND: Donor safety has always been a major concern and potential risk to the donor must be balanced against recipient benefit. However, lack of a standard
期刊
liverTRANSPLANTATIONLIVINGDONORriskFACTORSsafetyliver transplantation li
Portopulmonary hypertension and serum endothelin levels in hospitalized patients with cirrhosis
BACKGROUND:Cirrhosis is associated with several extrahepatic manifestations including portopulmonary hypertension (PPHT).Recent data suggest that endothelins (E
期刊
CIRRHOSISportopulmonaryHYPERTENSIONENDOTHELINcirrhosisportopulmonary hypert
YKL-40 expression in human hepatocellular carcinoma:a potential biomarker?
BACKGROUND:YKL-40 is a new biomarker with diagnostic value in many different cancers.Whether it may serve as a biomarker for hepatocellular carcinoma (HCC) is s
期刊
YKL-40HEPATOCELLULARCARCINOMACIRRHOSISYKL-40hepatocellular carcinomacirrho
Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantati
BACKGROUND:Liver transplantation(LT)is an effective therapy for end-stage hepatitis B virus(HBV)infection. Recurrence of HBV is one of the frequent complication
期刊
livertransplantationhumanLEUKOCYTEANTIGENHEPATITISBvirusRECURRENCEliver